Back
Markel Group, Inc. 10K Form
Sell
37
MKL
Markel Group, Inc.
Last Price:
$2,060.90
Seasonality Move:
3.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-01 | 10Q | MKL/Markel Group, Inc. Quarterly |
| 2023-08-02 | 10Q | MKL/Markel Group, Inc. Quarterly |
| 2023-04-26 | 10Q | MKL/Markel Group, Inc. Quarterly |
| 2022-11-01 | 10Q | MKL/Markel Group, Inc. Quarterly |
| 2022-08-02 | 10Q | MKL/Markel Group, Inc. Quarterly |
| 2022-04-26 | 10Q | MKL/Markel Group, Inc. Quarterly |
Receive MKL News And Ratings
See the #1 stock for the next 7 days that we like better than MKL
MKL Financial Statistics
Sales & Book Value
| Annual Sales: | $16.6B |
|---|---|
| Cash Flow: | $1.2B |
| Price / Cash Flow: | 11.09 |
| Annual Sales: | $1,429.48 |
| Price / Book: | 1.44 |
Profitability
| EPS (TTM): | 169.75320 |
|---|---|
| Net Income (TTM): | $2.2B |
| Gross Margin: | $0 |
| Return on Equity: | 11.93% |
| Return on Assets: | 4.06% |
Markel Group, Inc. Earnings Forecast
Key Markel Group, Inc. Financial Ratios
-
The Gross Profit Margin over the past 38 years for MKL is 0.00%.
-
The Selling, General & Administrative Expenses for MKL have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 9.57% of Operating Income.
-
The Net Earning history of MKL is 12.97% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 21 years.
Markel Group, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | MKL |
| CUSIP: | 570535 |
| Website: | mklgroup.com |
Debt
| Debt-to-Equity Ratio: | 0.24 |
|---|---|
| Current Ratio: | 0.71 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.18 |
|---|---|
| Forward P/E Ratio: | 16.68 |
MKL Technical Analysis vs Fundamental Analysis
Sell
37
Markel Group, Inc. (MKL)
is a Sell
Is Markel Group, Inc. a Buy or a Sell?
-
Markel Group, Inc. stock is rated a SellThe current Markel Group, Inc. [MKL] share price is $2,061.88. The Score for MKL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.